69 related articles for article (PubMed ID: 11922706)
21. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis.
Blümcke I; Luyken C; Urbach H; Schramm J; Wiestler OD
Acta Neuropathol; 2004 May; 107(5):381-8. PubMed ID: 15034726
[TBL] [Abstract][Full Text] [Related]
22. Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.
Mittelbronn M; Simon P; Löffler C; Capper D; Bunz B; Harter P; Schlaszus H; Schleich A; Tabatabai G; Goeppert B; Meyermann R; Weller M; Wischhusen J
J Neuroimmunol; 2007 Sep; 189(1-2):50-8. PubMed ID: 17675252
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.
Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q
J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584
[TBL] [Abstract][Full Text] [Related]
24. Tropomyosin isoform expression in normal and neoplastic astrocytes.
Galloway PG; Likavec MJ; Perry G
Lab Invest; 1990 Feb; 62(2):163-70. PubMed ID: 1689409
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of 5-lipoxygenase in high-grade astrocytomas.
Nathoo N; Prayson RA; Bondar J; Vargo L; Arrigain S; Mascha EJ; Suh JH; Barnett GH; Golubic M
Neurosurgery; 2006 Feb; 58(2):347-54; discussion 347-54. PubMed ID: 16462489
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of frizzled 9 in astrocytomas.
Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.
Broholm H; Laursen H
APMIS; 2004; 112(4-5):257-63. PubMed ID: 15233640
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Numb expression in astrocytomas.
Yan B; Omar FM; Das K; Ng WH; Lim C; Shiuan K; Yap CT; Salto-Tellez M
Neuropathology; 2008 Oct; 28(5):479-84. PubMed ID: 18384513
[TBL] [Abstract][Full Text] [Related]
29. Fascin expression in 90 patients with glioblastoma multiforme.
Roma AA; Prayson RA
Ann Diagn Pathol; 2005 Dec; 9(6):307-11. PubMed ID: 16308158
[TBL] [Abstract][Full Text] [Related]
30. Expression of microtubule-associated proteins, MAP-1 and MAP-2, in human neuroblastomas and differential diagnosis of immature neuroblasts.
Artlieb U; Krepler R; Wiche G
Lab Invest; 1985 Dec; 53(6):684-91. PubMed ID: 3906271
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
32. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
[TBL] [Abstract][Full Text] [Related]
33. Expression and release of CD14 in astrocytic brain tumors.
Deininger MH; Meyermann R; Schluesener HJ
Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
[TBL] [Abstract][Full Text] [Related]
34. Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C; Higgins JP; West RB; Natkunam Y; Heerema-McKenney A; Arber DA
Am J Surg Pathol; 2009 Nov; 33(11):1695-704. PubMed ID: 19701075
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.
Torp SH
Clin Neuropathol; 2002; 21(6):252-7. PubMed ID: 12489673
[TBL] [Abstract][Full Text] [Related]
36. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
37. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
[TBL] [Abstract][Full Text] [Related]
39. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
Kirla RM; Haapasalo HK; Kalimo H; Salminen EK
Cancer; 2003 Feb; 97(3):644-8. PubMed ID: 12548606
[TBL] [Abstract][Full Text] [Related]
40. [Endothelin-1 expression and quantitative analysis in astrocytomas].
Li JM; Wu XL; Zhu QJ; Wang QJ
Ai Zheng; 2002 Oct; 21(10):1109-11. PubMed ID: 12508654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
